Agustina Errea

Title: Agustina Errea: Innovator in Vaccine Development

Introduction

Agustina Errea is a prominent inventor based in La Plata, Buenos Aires, Argentina. She has made significant contributions to the field of vaccine development, particularly in the prevention of infections. Her innovative work has led to the creation of a vaccine that utilizes outer membrane vesicles (OMVs) and various adjuvants to enhance immune response.

Latest Patents

Agustina holds 1 patent for her groundbreaking vaccine. This vaccine comprises at least outer membrane vesicles (OMVs) and includes excipients and/or adjuvants. The formulation can contain adjuvants such as aluminum hydroxide and immunogens like tetanus toxoid and diphtheria toxoid. The vaccine is designed to deliver between 3 to 20 µg per dose of OMVs and a specific amount of lipopolysaccharide from bacteria. This innovative approach aims to provide effective prevention against infections.

Career Highlights

Throughout her career, Agustina has worked with esteemed institutions such as the National Scientific and Technical Research Council (CONICET) and the National University of La Plata. Her research has focused on developing effective vaccines that can significantly impact public health.

Collaborations

Agustina has collaborated with notable colleagues, including Daniela Hozbor and Daniela Bottero. These partnerships have contributed to her success in the field of vaccine research and development.

Conclusion

Agustina Errea is a trailblazer in the field of vaccine innovation, with her work promising to enhance the prevention of infections. Her dedication to research and collaboration with esteemed institutions and colleagues underscores her commitment to advancing public health through innovative solutions.